82 results
SC 14D9/A
KNTE
Kinnate Biopharma Inc
22 Mar 24
Tender offer solicitation (amended)
5:14pm
the Company could further consider, including the timelines, benefits and drawbacks of various transaction structures and counterparties. Following discussion
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
continued
regulatory approval, (viii) demonstrate the actual and perceived benefits of any product related to the CVR Products, if approved, relative … or benefits under any Company Benefit Plan, or the funding of any payments or benefits under any Company Benefit Plan or (vii) hire or terminate
SC 14D9
EX-99
KNTE
Kinnate Biopharma Inc
4 Mar 24
Tender offer solicitation
5:27pm
of a Change in Control.
Finally, it is understood, that if for whatever reason, the Company or its successor is unable to provide for COBRA benefits
SC 14D9
EX-99
KNTE
Kinnate Biopharma Inc
4 Mar 24
Tender offer solicitation
5:27pm
of a Change in Control.
Finally, it is understood, that if for whatever reason, the Company or its successor is unable to provide for COBRA benefits during
SC 14D9
EX-99
KNTE
Kinnate Biopharma Inc
4 Mar 24
Tender offer solicitation
5:27pm
, the Company or its successor is unable to provide for COBRA benefits during the period of your continuing coverage, then the Company or its successor will pay
SC 14D9
cjdzgbzl
4 Mar 24
Tender offer solicitation
5:27pm
SC 14D9
EX-99
aju 5l4m1
4 Mar 24
Tender offer solicitation
5:27pm
SC TO-T
EX-99
h67nt
4 Mar 24
Third party tender offer statement
5:24pm
SC TO-T
EX-99
lfc7bz
4 Mar 24
Third party tender offer statement
5:24pm
8-K
EX-2.1
8qc4v4
1 Mar 24
Entry into a Material Definitive Agreement
8:50am
8-K
EX-2.1
kon0ojusaq87a
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
8-K
a0p0zi37
16 Jan 24
Regulation FD Disclosure
4:05pm
8-K
p6x2pet 0hshi2
22 Nov 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
pctife5ywxgu
18 Sep 23
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
4:28pm
8-K
45hmbqboaed1q
18 Sep 23
Kinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce Restructuring
4:28pm
8-K
EX-99.1
gur63 tyagjnf629mt
8 Aug 23
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
4:16pm
8-K
EX-99.1
icfo7hzvjth xc3
11 May 23
Kinnate Biopharma Inc. Reports First Quarter 2023 Financial Results and Recent Corporate Updates
4:15pm